NCT01733186View on ClinicalTrials.gov

Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 7, 2013

Primary Completion Date

June 2, 2017

Study Completion Date

August 29, 2017

Conditions

Degeneration Articular Cartilage Knee

Interventions

BIOLOGICAL

CARTISTEM®

Trial Locations (2)

60612

Cartilage Restoration Center; RUSH University Medical Center, Chicago

02467

Cartilage Repair Center; Brigham and Women's Hospital, Chestnut Hill

All Listed Sponsors

lead

Medipost Co Ltd.

INDUSTRY

NCT01733186 - Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects | Biotech Hunter | Biotech Hunter